AMP 2026 has ended. This guide stays up as the record of who was there. Next: AMP 2027, Nov 9–13, 2027 in Baltimore
Foundation Medicine at AMP 2026
Nov 10–14, 2026 Seattle, WA ~2k attendees Website
Foundation Medicine brings 3 presentations to AMP 2026 in Seattle, and exhibits at Booth 1701, MR14. Its sessions cover molecular residual disease in breast cancer and the surveillance decisions that follow, plus HLA class I typing drawn from comprehensive genomic profiling. It also joins an education session on adapting communication strategies for today's pathology learners.
| Organization | AMP 2026 Attendance |
|---|---|
Foundation Medicine Boston, MA | |
Molecular information company providing comprehensive genomic profiling to inform cancer treatment decisions. | Booth Exhibiting at Booth 1701, MR14 Thu, Nov 1211:15am–7:00pmFri, Nov 139:00am–4:00pmSat, Nov 149:00am–1:30pm Workshop Wed, Nov 11 8:00am–8:50am Molecular Residual Disease in Breast Cancer: Advancing Surveillance and Clinical Decision-Making Tissue-informed circulating tumor DNA testing in breast cancer, from baseline through surveillance and early recurrence detection. Workshop Wed, Nov 11 9:00am–9:50am Advancing HLA Class I Typing Through Comprehensive Genomic Profiling Adding HLA class I typing to comprehensive genomic profiling, with immuno-oncology uses from checkpoint inhibitors to cell therapy. Talk Thu, Nov 12 7:15am–8:15am Adapting Communication Strategies for Today's Pathology Learners (A Special EdCoP Event) Teaching pathology trainees across generations and learning styles, including feedback and handling performance problems. |
Find decision makers at Foundation Medicine
Tell us what you sell and we’ll find the people at Foundation Medicine most likely to buy it.
- Who to contact
- Their contact info
- What to say
- Free, no sign-up
Not affiliated with the Association for Molecular Pathology. Organization details are derived from AMP’s published lists. Submit a correction